novel: search

PW Collaborate on Second Breakthrough Novel Award">Book News: Amazon.com, Penguin, PW Collaborate on Second Breakthrough Novel Award

Amazon.com and the Penguin Group again will host the Amazon Breakthrough Novel Award, described as an “international competition seeking the next popular novel.� Amazon said that “writers around the world are encouraged to begin preparing their manuscripts for entry into the competition, which is scheduled to launch on February 2, 2009.� As with the inaugural award, Publishers Weekly is serving as the reviewing sponsor. The magazine’s reviewers will read, rate, and review manuscripts and select 100 semifinalists. Penguin editors will evaluate the PW picks and choose the three finalists. A panel of top publishing professionals, including bestselling authors Sue Grafton and Sue Monk Kidd, literary agent Barney Karpfinger, and Penguin Press editor-in-chief Eamon Dolan will read and post their critiques of the top three manuscripts

Legendary Graphic Novel Now on Sale

GamingShogun writes, "Spark Unlimited announced today that its 96-page graphic novel adaptation of Legendary is now on shelves. Written by comic book veteran, Mark Waid, and penciled by Top Cow Production artist Martin Montiel, readers are given further insight into Charles Deckard, the main character of both the graphic novel and the game..."

ScinoPharm gets US patent for novel crystal forms of Irinotecan Hydrochloride

ScinoPharm, an active pharmaceutical ingredient (API) specialist, has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.

ScinoPharm Granted US Patent for Novel Crystal Forms

PRNewswire-Asia/ -- ScinoPharm, an active pharmaceutical ingredient (API) specialist, announced it has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.

ScinoPharm Granted US Patent for Novel Crystal Forms

TAINAN, Taiwan, Nov. 25 /PRNewswire-Asia/ -- ScinoPharm, an active pharmaceutical ingredient (API) specialist, announced it has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.

ScinoPharm Granted US Patent for Novel Crystal Forms

TAINAN, Taiwan, Nov. 25 /PRNewswire-Asia/ -- ScinoPharm, an active pharmaceutical ingredient (API) specialist, announced it has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.

ScinoPharm Granted US Patent for Novel Crystal Forms

TAINAN, Taiwan, November 25, 2008 /PRNewswire-Asia/ -- ScinoPharm, an active pharmaceutical ingredient (API) specialist, announced it has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.

Book review: 'Thames' and 'By Chance'

From his first novel, "The Great Fire of London," to this new book's ambitious harbinger, "London: The Biography," the city as theater has fueled Peter Ackroyd's writing. His biographies of Sir Thomas More, William Blake, Charles Dickens and T.S. Eliot were richly enhanced by their London settings, in particular the brooding presence of the Thames. His novel "The House of Doctor Dee" evoked an Elizabethan manor overlooking the river, and in another novel, "Hawksmoor," the orderly world of London's great Baroque churches was shattered by glimpses of the charnel-houses, Celtic sites and Roman temples that lie buried beneath their watery crypts.

New Asimov Movies Coming

bowman9991 writes "Two big budget Isaac Asimov novel adaptations are on the way. New Line founders Bob Shaye and Michael Lynne are developing Asimov's 1951 novel Foundation, the first in Asimov's classic space opera saga, which has the potential to be as epic as Lord of the Rings. At the same time, New Regency has recently announced they were adapting Asimov's time travel novel The End of Eternity. Despite having edited or written more than 500 books, it's surprising how little of Isaac Asimov's work has made it to the big screen. '"Isaac Asimov had writer's block once," fellow science fiction writer Harlan Ellison said, referring to Asimov's impressive output. "It was the worst ten minutes of his life."' Previous adaptations include the misguided Will Smith feature I, Robot, the lame Bicentennial Man with Robin Williams, and two B-grade

Novel handheld LED device effective for photoaged skin

MedWire News: Combination red and infrared light-emitting diode (LED) therapy delivered from a novel handheld device is an effective method for treating photoaged skin, says Neil Sadick of Weill Medical College of Cornell University in New York, USA.

A ''novel'' entry into blogosphere

This Malayalam novelist feels serializing the novel through blog is a better way to reach out to the readers

A 'novel' entry into blogosphere

This Malayalam novelist feels serializing the novel through blog is a better way to reach out to the readers

British novel, 'The Northern Clemency,' tops Amazon's list for 2008

NEW YORK - Philip Hensher's "The Northern Clemency" is a British novel that as of Sunday had yet to attract any customer reviews on Amazon.com. But the online retailer's staff reviewers have noticed well, making it Amazon's book of the year.

Best Poster Award at UK NanoForum 2008 goes to Novel OPV Design

Research on a novel organic photovoltaic design presented by researchers at the Advanced Technology Institute (ATI) at the University of Surrey has won first prize in the recently concluded UK NanoForum 2008, jointly organised by the Engineering and Physical Sciences Research Council (EPSRC) and UK Trade and Investment.

Google Maps hack turns book into geo-novel

In its current incarnation, Christoph Benda's first novel requires that you a) be able to read German and b) have an internet connection.

Google Maps hack turns book into geo-novel

In its current incarnation, Christoph Benda's first novel requires that you a) be able to read German and b) have an internet connection.

ScinoPharm Granted US Patent for Novel Crystal Forms

TAINAN COUNTY, TAIWAN - ScinoPharm, an active pharmaceutical ingredient (API) specialist, announced it has been granted US Patent No. 7,435,818 entitled “Novel Crystal Forms of Irinotecan Hydrochloride”.

Mythic and The Black Library Announce Dark Storm Gathering Novel

dailygamesnews.com - Mythic and The Black Library, a division of Games Workshop, today announced Dark Storm Gathering, an original novel based on the critically acclaimed MMORPG, Warhammer Online: Age of Reckoning (WAR).

Compellis Pharmaceuticals, Inc. Awarded Second Broad Patent From the U.S. Patent Office for Novel Obesity Therapy

Compellis Pharmaceuticals, Inc. Awarded Second Broad Patent From the U.S. Patent Office for Novel Obesity Therapy

Compellis Pharmaceuticals, Inc. Awarded Second Broad Patent From the U.S. Patent Office for Novel Obesity Therapy

Compellis Pharmaceuticals, Inc. Awarded Second Broad Patent From the U.S. Patent Office for Novel Obesity Therapy

Viral DNA in bacterial genome could hold key to novel cystic fibrosis treatments

The bacterium Pseudomonas aeruginosa is well known for its environmental versatility, ability to cause infection in humans, and its capacity to resist antibiotics. P. aeruginosa is the most common cause of persistent and fatal lung infections in cystic fibrosis patients. In a study published in Genome Research, researchers have used genomic techniques to study a particularly virulent strain of P. aeruginosa, uncovering genetic clues to its success that will aid in the design of novel therapeutic strategies.

Viral DNA in bacterial genome could hold key to novel cystic fibrosis treatments

December 2, 2008 The bacterium Pseudomonas aeruginosa is well known for its environmental versatility, ability to cause infection in humans, and its capacity to resist antibiotics. P. aeruginosa is the most common cause of persistent and fatal lung infections in cystic fibrosis patients. In a study published online today in Genome Research (www.genome.org), researchers have used genomic techniques to study a particularly virulent strain of P. aeruginosa, uncovering genetic clues to its success that will aid in the design of novel therapeutic strategies.

How evolution learns from past environments to adapt to new environments

The evolution of novel characteristics within organisms can be enhanced when environments change in a systematic manner, according to a new study by Weizmann Institute researchers. Merav Parter, Nadav Kashtan and Uri Alon suggest that in environments that vary over time in a non-random way, evolution can learn the rules of the environment and develop organisms that can readily generate novel useful traits with only a few mutations. Details are published November 7 in the open-access journal PLoS Computational Biology.

William Wharton

When William Wharton's first novel, Birdy, was published in 1979, he was already 53 years old, an American expatriate painter living in Paris. But his identity remained a mystery, because Wharton, who has died aged 82, chose that name as a pseudonym for his writing, while painting under his real name, Albert du Aime. The Wharton persona was soon the better known, as Birdy became an instant bestseller, won the American Book award for best first novel, and was a finalist for the Pulitzer prize. It was adapted in 1984 by Alan Parker into a well-received film, starring Matthew Modine and Nicolas Cage.

Search took 0.02 seconds.